CRP and rheumatoid arthritis: MTX non-responders had a longer duration of RA (p < 0.01), more tender and swollen joints (p < 0.01 each), higher VAS and DAS28 scores (p < 0.01 each), and higher ESR and CRP (p < 0.01 each).